Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 117 results: Page 1 of 5


Tier Species Size Attr. GeneSet
Tier II 679 GS223766: Proteinuria QTL 3 (Pur3 Published QTL Chr 15)
Tier II 414 GS84270: high-dose ethanol actions (Published QTL, Chr 14)
Tier II 415 GS223582: Body weight QTL 7 (Bw7 Published QTL Chr 15)
Tier II 604 GS224038: Plasma insulin-like growth factor 1 level QTL 8 (Pigfal8 Published QTL Chr 15)
Tier II 870 GS225010: Bone structure and strength QTL 19 (Bss19 Published QTL Chr 15)
Tier II 608 GS225020: Coat color QTL 3 (Coatc3 Published QTL Chr 15)
Tier II 851 GS224622: Serum cholesterol level QTL 1 (Scl1 Published QTL Chr 15)
Tier II 763 GS224678: Bone structure and strength QTL 103 (Bss103 Published QTL Chr 15)
Tier II 949 GS224882: Neuroinflammation QTL 12 (Neuinf12 Published QTL Chr 15)
Tier II 779 GS223147: Bone structure and strength QTL 29 (Bss29 Published QTL Chr 15)
Tier II 811 GS223220: Glomerulus QTL 26 (Glom26 Published QTL Chr 15)
Tier II 684 GS223359: Alcohol response QTL 14 (Alcrsp14 Published QTL Chr 15)
Tier II 813 GS224050: Renal function QTL 42 (Rf42 Published QTL Chr 15)
Tier II 870 GS224183: Bone mineral density QTL 18 (Bmd18 Published QTL Chr 15)
Tier II 870 GS224184: Bone mineral density QTL 17 (Bmd17 Published QTL Chr 15)
Tier II 750 GS224690: Glucose level QTL 24 (Gluco24 Published QTL Chr 15)
Tier IV 51914 GS405734: WWP1 KO vs WT
Tier II 18580 GS235234: [MeSH] Biochemical Phenomena : D001669
Tier II 18580 GS238030: [MeSH] Chemical Phenomena : D055598
Tier II 20142 GS241072: [MeSH] Genetic Phenomena : D055614
Tier II 18221 GS241889: [MeSH] Molecular Structure : D015394
Tier II 17707 GS243325: [MeSH] Base Sequence : D001483
Tier II 19954 GS243722: [MeSH] Genetic Structures : D040342
Tier IV 2311 GS400104: Genes with downregulated whole blood RNA levels in severe COVID-19 patients versus healthy controls
Tier IV 352 GS400102: Genes with downregulated whole blood transcription in severe versus mild COVID-19 patients